Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
Simone Boneckera, Marina Magnagob, Jaspal Kaedac, Cristiana Solzab, Ilana Zalcberg Renaulta,
Corresponding author
zalcberg@inca.gov.br

Corresponding author at: Praça Cruz Vermelha, 23, 6° andar, Laboratórios CEMO, Centro, 20230-130 Rio de Janeiro, RJ, Brazil.
a Instituto Nacional do Câncer (INCA), Rio de Janeiro, RJ, Brazil
b Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brazil
c Universitätsmedizin Berlin, Berlin, Germany
Read
1343
Times
was read the article
490
Total PDF
853
Total HTML
Share statistics
Article information
ISSN: 15168484
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 7 9 1 10
2025 6 42 17 59
2025 5 43 12 55
2025 4 31 10 41
2025 3 41 11 52
2025 2 44 25 69
2025 1 33 17 50
2024 12 26 20 46
2024 11 26 24 50
2024 10 40 23 63
2024 9 43 16 59
2024 8 49 28 77
2024 7 24 15 39
2024 6 36 19 55
2024 5 42 29 71
2024 4 32 13 45
2024 3 32 19 51
2024 2 30 19 49
2024 1 31 15 46
2023 12 23 26 49
2023 11 33 26 59
2023 10 23 31 54
2023 9 31 24 55
2023 8 16 17 33
2023 7 20 5 25
2023 6 24 10 34
2023 5 17 10 27
2023 4 12 8 20
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy